Navigation Links
Life Sciences Discovery Fund advances latest research proposals
Date:9/19/2008

Seattle (September 17, 2008) Ten Washington State-based life sciences research teams will progress to the interview round in the Life Sciences Discovery Fund's latest grants competition, "Innovative Programs to Advance Health Research." A total of up to $20 million in funding is available in this competition. Funding in this competition will help Washington research organizations and institutions launch new programs of research.

Expert review of proposals in this competition occurs in two stages: a panel review of all proposals followed by interviews of a subset of applicants chosen by the Life Sciences Discovery Fund's Board of Trustees at its September 16, 2008 meeting. All proposals are reviewed for: their scientific, technical and organizational merit; the importance of the research to health and health care; and the potential for the research to create economic returns to Washington State. The ten principal investigators and programs selected for interviews are:

  • Gwenn Garden, "Neurotherapeutics Evaluation Center," University of Washington
  • Mary Larimer, "Center for the Study of Health and Risk Behavior," University of Washington
  • Thomas Rea, "Program to Integrate Technology and Cardiac Arrest Resuscitation," King County (Washington) Department of Public Health
  • Karin Rodland, "Integrated Program in Chronic Pulmonary Disease," Battelle, Pacific Northwest Division
  • John Roll, "Program of Excellence in Rural Mental Health and Substance Abuse Treatment," Washington State University
  • Lawrence Corey, "Washington Vaccine Alliance," Fred Hutchinson Cancer Research Center
  • Patrick Stayton, "Center for Intracellular Delivery of Biologics," University of Washington
  • Jonathan Himmelfarb, "Development of a Chronic Kidney Disease Collaborative," University of Washington
  • Beverly Torok-Storb, "Cell-Based Therapies Through Reprogramming and Cell Fate Control," Fred Hutchinson Cancer Research Center
  • Matthew
    '/>"/>

Contact: Dianne Needham
needham@lsdfa.org
206-732-6776
Life Sciences Discovery Fund
Source:Eurekalert

Page: 1 2

Related biology news :

1. UCI receives $5M from Edwards Lifesciences
2. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
3. Computational mathematical sciences receives NSF grant for undergraduate research
4. Widespread support for nonembryonic stem cell research, VCU Life Sciences Survey shows
5. A special issue of the International Journal of Plant Sciences
6. Media advisory -- 2008 Ocean Sciences Meeting
7. 2008 Ocean Sciences Meeting -- media advisory 2
8. Outstanding undergraduates recognized in agronomy, crop, soil, and environmental sciences
9. Nobel laureate Dr. Linda Buck elected to American Academy of Arts & Sciences 2008 Class of Fellows
10. UT Southwesterns Mangelsdorf elected to National Academy of Sciences
11. UMass Medical Schools Craig Mello elected to American Academy of Arts and Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... School of Public Health at Emory University, along ... have received a $4 million grant over four ... University (Health and Exposome Research Center: Understanding Lifetime ... grant awarded in the United States. , ... Institute of Environmental Health Sciences (NIEHS) of the ...
(Date:5/23/2013)... new report from the Institute of Medicine says schools ... least 60 minutes of vigorous or moderate intensity activity ... of American youth meet current evidence-based guidelines of at ... activity daily, according to the report, which was released ... nearly half of their waking hours, the committee recommends ...
(Date:5/23/2013)... when microbial pathogens are growing increasingly resistant to the ... of Wisconsin scientists has synthesized a potent new class ... staph infections. , Writing online in the Journal ... by University of Wisconsin-Madison chemistry Professor Helen Blackwell describes ... of Staphylococcus aureus , a bacterium at the ...
Breaking Biology News(10 mins):Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Schools should provide students with daily physical activity, IOM recommends 2University of Wisconsin chemists find new compounds to curb staph infection 2
... clumps of protein found within nerve cells are ... were first identified in the early 1900s by German ... in a protein called tau cause it to aggregate ... Normally, the tau protein is involved in the formation ...
... of cardiovascular disease, research from the Sahlgrenska Academy at the ... obesity hormones adiponectin - are also linked to osteoporosis ... is more than just bones, vertebrae and joints. In fact, ... our brain, our muscles and our fatty tissue. Stem cells ...
... D deficiency is common in Americans, and especially in ... of Health. University of Missouri researchers have found that ... vitamin D3 is safe and effective in improving their ... risk for deficiency because they tend to absorb vitamin ...
Cached Biology News:Chemical engineers help decipher mystery of neurofibrillary tangle formation in Alzheimer's brains 2Obese adolescents benefit from high-dose vitamin D supplements 2
(Date:5/24/2013)... May 24, 2013 Vestiage, Inc. ... company focused on science-based research and development, sales ... cosmeceuticals and nutraceuticals, announced today that it is ... for the sale of Reluma Skin Illuminating Facial ... and application by sending an email to info(at)vestiageinc(dot)com ...
(Date:5/23/2013)... May 23, 2013 Venaxis, Inc. (Nasdaq:   ... on obtaining FDA clearance and commercializing its rapid, protein ... pricing of an underwritten public offering of 10,000,000 shares ... 3,500,000 shares of its common stock at an exercise ... offering price of $1.25 per share and related warrant.  ...
(Date:5/23/2013)... Patheon Inc ., a leading ... global pharmaceutical industry, will host a complimentary webinar on ... on Tuesday, June 4, 2013 at 11 a.m. Eastern ... to comply with regulations for cleaning validation. Many ... underpinning and little evaluation of risk. Some companies ...
(Date:5/23/2013)... 23, 2013 PI’s new LPS-24 ... provide 15 mm travel range with closed-loop sensor ... dimensions make these new positioners the ideal choice ... vacuum rated version is also available. , ... datasheets can be found at: , http://www.physikinstrumente.com/en/products/prdetail.php?sortnr=1000745&prw-lps24 ...
Breaking Biology Technology:Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2
... GenVault,s energy and space efficient technologies ideally suit ... create a new paradigm for eco-friendly, sustainable Biobanking ... announces the opening of its newly-formed Japanese subsidiary ... the expanding Biobanking market and its growing customer ...
... Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, today ... ophthalmic gel, 0.15%, has been accepted for review by ... is seeking approval for ganciclovir as a treatment for ... simplex virus. The FDA has issued an action date ...
... 26 Fifty percent of clinical trial management ... share high-value, proprietary company information via e-mail, while ... overnight courier (14 percent), according to a recent ... for exchanging clinical trial information with outside parties ...
Cached Biology Technology:GenVault Opens Japanese Subsidiary to Better Address Global Biobanking Market Growth 2Sirion Therapeutics New Drug Application for Ganciclovir is Accepted for Review by the FDA for the Treatment of Ocular Herpes 2Sirion Therapeutics New Drug Application for Ganciclovir is Accepted for Review by the FDA for the Treatment of Ocular Herpes 3IntraLinks Poll: Half of Clinical Trial Management Professionals Share Critical Information Via E-Mail 2
The Spheroplast Kit contains qualified reagents for the preparation of yeast spheroplasts. The reagents have been optimized for use with Pichia pastoris and are guaranteed to generate 70% spheroplast...
DEAD (Asp-Glu-Ala-Asp) box polypeptide 5...
... Our fastest automated perfusion system. For ... perfusion, physiology, biophysics, electrochemistry, or general ... with 1.5-4 millisecond accuracy Run ... Microprocessor-based for accuracy and flexibility ...
Mycoplasma tested...
Biology Products: